Home>Topics>Funds>Biotech HOLDRs

Biotech HOLDRs BBH

  1. All
  2. Commentary
  3. Video Reports
  4. Fund Reports
  5. ETF Reports
  6. Headlines
    1. Dynamic And Durable Growth (Part 1)

      Headlines

      Thu, 24 Jul 2014

      By Invesco : By Janet Luby Part 1: A Biotech/Pharma Revolution This is the first in a four-part series examining dynamic and durable growth themes that affect the U.S. economy and may present opportunities for investors. The remaining three blog posts will examine the enormous implications of shale

    2. Biotechs Have Their 'Irrational Exuberance' Moment: Time To Buy More?

      Headlines

      Mon, 21 Jul 2014

      By DoctoRx : Background : When the Fed noted some froth in "smaller" biotechs last week, large ones also got slammed. Biogen Idec (NASDAQ: BIIB ) fell more than 7% after that statement. Gilead Sciences (NASDAQ: GILD ) fell 5% peak-to-trough. Small ones got dumped big-time. Is it but a passing ...

    3. This week's selloff looking like March's

      Headlines

      Tue, 8 Jul 2014

      decline - to commence later this month or early August, and he suggests investors begin raising cash. Biotech ETFs: XBI , BBH , FBT , PBE Low-vol ETFs: SPLV , LGLV , CFA , CFO Utility ETFs: XLU , IDU , VPU , UPW , FUTY , RYU , FXU , PUI , SDP , PSCU

    4. Buyout Cycle Boosts Biotech ETFs

      Headlines

      Fri, 13 Jun 2014

      By David Fabian : The recent buyout of Idenix Pharmaceuticals ( IDIX ) by drug maker Merck & Co. ( MRK ) is another high-profile example of the race to scoop up promising biotechnology companies before they hit it big. Drug companies know the pipeline for new products must constantly be refreshed

    5. Idenix deal fuels rally in (certain) biotech ETFs

      Headlines

      Mon, 9 Jun 2014

      ETFs with a focus on large caps - the iShares Nasdaq Biotechnology ETF ( IBB +0.5% ) and the Market Vectors Biotech ETF ( BBH +0.4% ) - are having more subdued sessions. Previously: Merck buys Idenix The rally in small cap biotech fueling a positive

    6. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

      Headlines

      Tue, 3 Jun 2014

      with Timothy Hartch and Michael Keller at BBH Core Select BBTEX "> BBTEX making a high-conviction ..... company's common stock. While the managers at BBH Select Core also put a little bit of money ..... during our last article , the managers at BBH Core Select made a high-conviction new-money

    7. 10 High-Conviction Purchases of Ultimate Stock-Pickers

      Headlines

      Tue, 20 May 2014

      Appreciation. The fund has been replaced with BBH Core Select BBTEX, which our fund team ..... characteristics with the manager it was replacing. BBH Core Select's managers--Tim Hartch ..... the team's valuation work. We expect BBH Core Select to be a solid addition to the

    8. IBB iShares Nasdaq Biotechnology ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 16 Apr 2014

      Biotech XBI and Market Vectors Biotech ETF BBH charge just 0.35%. Still, we think ..... 0.63%) and Market Vectors Biotech BBH (0.35%). The Market Vectors ETF is ..... Celgene, and Biogen). As a result, BBH 's portfolio of 25 biotech stocks has an

    9. XBI SPDR S&P Biotech ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 16 Apr 2014

      Biotech & Genome PBE (0.63%) and Market Vectors Biotech BBH (0.35%). The Market Vectors ETF is more of a traditional ..... think Amgen, Gilead, Celgene, and Biogen). As a result, BBH 's portfolio of 25 biotech stocks has an average market cap

    10. FBT First Trust NYSE Arca Biotech Index ETF Analysis, Report, Research, 5 Star Rating – Morningstar

      ETF Reports

      Wed, 16 Apr 2014

      Biotech & Genome PBE (0.63%) and Market Vectors Biotech BBH (0.35%). The Market Vectors ETF is more of a traditional ..... think Amgen, Gilead, Celgene, and Biogen). As a result, BBH 's portfolio of 25 biotech stocks has an average market cap

    « Prev12345Next »
    Content Partners